Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICU

Study ID: NCT07274969
Start Date: 2026-06-30
End Date: 2027-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Heart Failure Carer Support Programme: Implementation Testing in the UK.

Study ID: NCT07373041
Start Date: 2026-03-01
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

360

Intervention / Treatment

HEart faiLure carer support Programme (HELP)

Sponsor

Queen's University, Belfast

Source: clinicaltrials.gov

Share:
Add to list

Photobiomodulation for Cancer-Related Cognitive Impairment

Study ID: NCT05855694
Start Date: 2026-04
End Date: 2029-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

THOR LED Photobiomodulation Helmet - Therapeutic

THOR LED Photobiomodulation Helmet - Control

Sponsor

Arash Asher, MD

Source: clinicaltrials.gov

Share:
Add to list

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Study ID: NCT05377320
Start Date: 2026-12
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Clinical Decision Aid

Standard Care

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

sElective Serotonin reuPtake inhibitoRs In posT-covid

Study ID: NCT07359482
Start Date: 2026-03-01
End Date: 2028-05-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

160

Intervention / Treatment

Fluvoxamine

Placebo

Sponsor

Academic Medical Center - University of Amsterdam (AMC-UvA)

Source: clinicaltrials.gov

Share:
Add to list

Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema

Study ID: NCT06881888
Start Date: 2026-08-31
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

60

Intervention / Treatment

Octreotide (drug)

Placebo

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Study ID: NCT07205796
Start Date: 2026-05-01
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

480

Intervention / Treatment

HZ Vaccine (IN001)

Shingrix

Sponsor

Shenzhen Shenxin Biotechnology Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

Deciphering the Genetic Architecture of Autoimmune Diseases

Study ID: NCT06948110
Start Date: 2026-02-03
End Date: 2030-04-22
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

National Human Genome Research Institute (NHGRI)

Source: clinicaltrials.gov

Share:
Add to list

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

Study ID: NCT07338981
Start Date: 2026-04
End Date: 2032-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

142

Intervention / Treatment

Nivolumab and Ipilimumab

Nivolumab + Ipilimumab

Sponsor

Guliz Ozgun

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight Without Type 2 Diabetes

Study ID: NCT07351045
Start Date: 2026-02-27
End Date: 2028-08-28
Study Type

Interventional

Study Phase

Phase3

No. of Participants

2000

Intervention / Treatment

Placebo

Spirit 068

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list